National Framework Agreement for the Supply of Generic Pharmaceuticals - Tenofovir Disoproxil/Emtricitabine and Tenofovir Disoproxil/Emtricitabine/Efavirenz
What the buyer wrote
Invitation to offer for National Framework Agreement for the Supply of Generic Pharmaceuticals - Tenofovir Disoproxil/Emtricitabine and Tenofovir Disoproxil/Emtricitabine/Efavirenz Offer reference number: CM/PHG/17/5545 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months Potential periods of call-offs under the framework agreement: North West London: 21/05/2019 to 31/10/2020 (18 months) North Central and East London: 21/05/2019 to 31/10/2020 (18 months) South East and West London: 21/05/2019 to 31/10/2020 (18 months) North of England: 21/05/2019 to 31/10/2020 (18 months) Midlands and East: 21/05/2019 to 31/10/2020 (18 mont…
Bid for this and lost? There is a short window in which the decision can be questioned.
Awarded to
Details
- What the buyer calls it
- National Framework Agreement for the Supply of Generic Pharmaceuticals - Tenofovir Disoproxil/Emtricitabine and Tenofovir Disoproxil/Emtricitabine/Efavirenz
- How they are buying
- Advertised, open to anyoneAny supplier could bid without being invited first.
- Type
- goods
- Suitable for small firms
- The buyer says yes. What that is worth
- Work starts
- 20 May 2019
- Work ends
- 31 Oct 2020
- Kind of work
- Pharmacy and medicines
Who the buyer named
The buyer published a contact address on this notice.